glp 1 agonist diarrhea Managing GLP-1/GIP side effects with diet and lifestyle Clinical Recommendations to Manage Gastrointestinal
Description
Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON
1 Thus, their clinical use is expected to grow rapidly not only because of the obesity epidemic but as evidence expands to other indications such as cardiorenal disorders, metabolic liver disease, obstructive sleep apnea, peripheral vascular disease, depression, addiction, and neurodegenerative diseases
July 2019
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Li W., Zhou Q., Cong Z., Yuan Q., Li W., Zhao F., Xu H.E., Zhao L.H., Yang D., Wang M.W
